Objective: To compare obsessive-compulsive (OC) symptoms in patients with Prader-Willi syndrome (PWS) and symptoms in a group of pat ients present ing with "Prader-Willi-like" features but without the gene tic abno rmalit ies associated with PWS . Method: 16 patients aged 4 through 20 years were evaluated in a clinic specializing in the asse ssment and management of behav ioral and food -related problems in PWS . Eight patients wer e found to have key features of the syndrome but did not have a PWS genotype. These PWS-like subjects were matched to 8 clinic patients with a confirmed deletion of the PWS critical regio n of the paternally derived chromosome 15. All subjects were evaluated for obes ity, 10, food-related problems , maladaptive behav iors, and non-food-related OC symptoms. Results: The re were no differences between the 2 groups with respect to mea sures of obesi ty, 10. food-related difficulties, or overall maladaptive behaviors. The PWS group show ed significantly greater numb ers of OC symptoms and greater symp tom severity. Conclusions: Patients with PWS have elevated numbe rs of OC symptoms and significant symptom -related impair ment which are not explained by developmental del ay, food-related difficulties, or obesity. OC symptoms are part of a behavioral phenotype that accompanies deletions on the proximal long arm of chromosome 15 in PWS .
of hyperph agia. w hic h reg ula rly lead s to severe foo dre lated diffi c ulties incl udi ng food foragi ng and lifethreaten ing ob esity (Prade r ct al., 19 56). H owever. th ose with PWS also su ffer from behavioral and emo tio na l d iffic ult ies not rela ted to foo d, incl ud ing temper tantrums, dramatic mood lability. stub bo rn ness, skin pickin g and o bs essive and co m p u lsive sy m p to ma to logy (Dykens and Cassidy, 19 9 5; D ykens et al., 1992 , 1996 ; W hi tma n and Accard o. 1987). M oreover. th e degree of resultin g psychiatric impairment is o ften very severe. W hile child ren and ado lescents with PWS ha ve, o n average, mi ld levels of cogn itive delay (C u rfs et al., 199 1; D yk en s cr al., 19 92 ), th eir beh avioral and psychiatric dysfunction typically results in highl y restri ctive levels of care and is often the so urce of enorm o us d istress for patients and th eir fam ilies (Hodapp et al., 1997 ) .
Recent stu d ies have underscored t he de gree to wh ich child ren, ado lescents, and ad ults wit h PW S suffer fro m non -food -related obsessive-co m p ulsive (OC) sym p to ms (D ykens and Ca ssidy, 19% ; D yken s ct al., 1996; Stein er al., 1994 ) . Dykens and co lleagues found th at PWS su b jects have an average of 3 d ifferent obsessions and compulsions as measured by the Yale-Brown O bsessive Co m p u lsive Scale (YBOCS) ( D yken s ct al. , 19 96 ) . STATE ET AI.. Moreover, when PWS patients are compared with nonmentally retarded adults with obsessive-compulsive disorder (OCD), the 2 groups are quite similar, demonstrating equal levels of symptom-related distress and functional impairment (Dykens et al., 1996) . These findings are particularly striking when contrasted with the relatively low prevalence of oeD in patients with retardation of mixed etiology (Menolascino et a!', 1986; Vitiello ct a!', 1989) .
In addition, Dykcns and Kasari identified a distinct set of signs and symptoms which reliably distinguished PWS children from children with Down syndrome or with nonspecific mental retardation. These included obsessions, compulsions, and skin picking (Dykcns and Kasari, 1997) . Other studies have supported high rates of repetitive behaviors, pcrseverativc speech, and skin picking in subjects with PWS (Clarke ct al., 1996; Schepis er al., 1994; Stein ct a!', 1994) .
However, questions remain about the strength of the association between OC symptoms and the PWS genotype. for instance, OC symptoms could conceivably arise as a psychological consequence of hyperphagia and may not be indicative of PWS per se, but rather a secondary characteristic of persons with significant food preoccupations. Along similar lines, the combination of excessive appetite and mild to moderate cognitive delay could lead to repetitive behaviors such as repeated questioning or the need for reassurance which might mistakenly be characterized as non-food-related OC symptoms, especially when studies rely on parental or caregiver report. Finally, researchers have tended to recruit subjects through PWS advocacy groups (Clarke er al., 1996; Dykcns and Kasari, 1997; Dykens er a!', 1996; Stein et a!', 1994) and therefore have difficulty controlling for the impact of reporting bias. It could be that parents and guardians of PWS subjects are inadvertently reconciling their reports of oe symptoms with widespread ideas about how persons with the syndrome generally behave.
To clarify the association of oe symptoms with the Pradcr-Willi genotype, we have compared subjects with PWS with a particularly powerful control group who presented to a clinic specializing in the assessment and treatment of behavioral problems in PWS. All subjects included in the study presented with key features of PWS including obesity, food preoccupations, maladaptive behaviors, and mild to moderate mental retardation or learning difficulties. However, patients in our comparison group were found not to have a genetic lesion asso-330 ciated with PWS. This "PWS-like" group was matched with a group of patients with a confirmed diagnosis of PWS because of a deletion on the paternally derived chromosome 15. We hypothesized that the 2 groups would show similar levels of behavioral problems bur that the PWS group would show higher rates of OC symptoms and symptom-related distress.
METHOD

Subjects
The study included 1(, subjects. 4-20 ycars of agc (mean 12.3 years). Eight subjects had PWS associated with a deletion of the I'WS critical region of the paternally inherited chromosome I'i. and H did not have a PWS genotypc. All study participants presented for evaluation to a clinic specializing in the assessment and treatment of behavioral and tood-rclarcd problems in PWS.
[)uring the first 12 months the clinic was in operation. a total of 8 children. adolescents, and young adults presented with behavioral complaints. difflcultics with Iood, and mild to moderate mental retardarion hut either faikd to meet diagnostic criteria for I'WS (Holm et al.. !')'),)l or had previously had genetic rcsring that did not identify a I'WS genotypc (Anonymous, 1')')6). Patients who presented to our clinic without .1 confirmed diagnosis of I'WS were o fTc red molecular gcnetic testing using mcthylarion-scnsit ive restriction cnzymcs to rule out abnormalirics on chromosome l'j at the locus q l l-q U (Anonymous. 1')')(,; Driscoll cr al., 1')')2). These tests were performed in the laboratory of Dr. Wayne Crody at LJCLA. The mcrhylarion-scnsitive restriction cnzyme technique allows identihcarion of the most common types of genetic problems that lead to PWS including delctionx on the paternally transmitted chromosome and maternal uniparental disorny (inheriting 2 copies of the maternal chromosome and no paternal chromosome). All patients catcgorizcd as PWS-likc in this study underwent this tcsting and were ncg.uiv« fi,r a PWS genotypc.
A total of 60 patients presented to the clinic over the same period who met clinical diagnostic criteria for I'WS and/or had confirmatory genctic testing (Anonymous. 1')')(,). From this group, the first H patients who presented chronologically to the clinic with confirmed deletions of chromosome l'j (either by cytogenetic analysis or Huorcsccncc in situ hybridizarion) and who matched the PWS-like group hy age and gender were idenrificd as the I'WS group.
At rh« time of initial evaluation, (, patients had a diagnosis of impulse control disorder not otherwise specified (NOS) (3 from the I'WS group and 3 from the I'WS-like group). One patient in the PWS-like group had a diagnosis of OCD and eating disorder NOS. and one patient from the PWS group had a diagnosis of anxiety disorder NOS. All patients with borderline intellectual functioning or mental rctardarion had the appropriate diagnoses on Axis II. One p.uicnr from each group had a history of seizures. One patient was raking medication fill obsessions and compulsions at the time of presentation. This subject was in the PWS-like group and was heing treated with a selective serotonin rcuprakc inhibitor,
Measures and Procedures
I'arenrs and carcgivers of patients who arranged fill evaluation in our clinic were mailed a previsir packer which they were asked to cornplcre prior to initial prcscnrarion. This packer included the fililowing:
f)"lJ/oj'; lilphic QI/'·51iolllll1ili·. A dem ograph ic qu esrionnairc requ ested iu fo rm arion r~ga rd i n g rhe pati ent's age. sex, IQ. height. weight, living an d work arrangcmcn rs, and gen~tic t~st in g status.
Parents a nd ca regive r» of all pat ients pr~s~nt ing 10 the clin ic fill~d UUl an info rma nt versio n of the YHO C S (C ood man ct al., 1'J89a ,b ), whic h has been shown 10 ha w guo d reliabil ity and validi ty (see Skc kercc er al., 1'J96: and Tay lor, 1'J'J'i ). T he version used in thi s srudv co ns ists u f a 'i6-item check list uf ( K : sy m p to ms whi ch is dra wn ' fro m th e ad u lt ve rsio n u f th e YHOCS, th ough it covers all sym plOm areas co n tai ned in th e chi ld version's checklist. Each item is rated as ht'ing pres~nt ever or in rhe pr evio u s week. Three addit ional ite ms asses s sy m p lOm sev eri ty. Infi lllll ants art' asknl to rare. on a S-p o in t xcale , the extent 10 wh ich obsessio n a nd compulsions ( I) art' tim e-consurn ing: (2) beh avio rs that arc rated on a scale from 0 10 2 (0 = not pr~s~nt; 1 = so mew ha t or som et imes true: 2 = vcrv t rue o r often true). Tlu-( :RCl. includes 8 "narrow-ha nd " and 2 bro :ltl-f.lClOr T sco res which den ot e overal l in rcr na lizin j; a nd cxt crual izin g beha vior s. C RC L T sco res greate r than 70 art' co nsidered 10 be in th e range of clinica l significa nce. T he C BC L is both a reliable an d valid mea sure uf psych op ath ology in ch ild ren and adolescents and has been used successfu lly in previou s studi es o f p~rsons with mental rerarda rio n .
During the initial evalu ation in clin ic, th ese measures were reviewed wi th a clin ician (M .W.S.. E.M .D.. H,H ,K. ). All the pati ents in th e study had a co m pleted set of instrumen ts. Sym pto m endorsem ents o n th e YROCS whi ch pert ained 10 foo d we re di scarded. For exampic. the checklist item "ritua lized cating beh avior s" was not inc luded in the tally of symplOms. On pre sent at ion 10 rhe clini c. all patients had vita l signs mea sured and reco rded . includ ing heart rate . blood p ressure . he ight. weight. and head ci rcu m ference , Body mass index (B M !) was calculated hy the for m u la wei ght (kgl/ he igh t ( ml (  Smal ley et 
RESULTS
Subject Characteristics
The PWS and PWS-like groups of patients were match ed for age and gender and then assessed for significant differences in IQ. height. weight, BMI. and tot al C BC L scores. One-way analyses of variance (ANOVAs) revealed no sign ifican t differen ces between groups. However, BMI approached statistical significance. with the PWS-like group tending to be more obese th an the PWS group. Table 1 shows the means, standard deviation s, and F values for all co mparisons. Given the trend toward significance in a measu re of obesity, an additional analysis was undertaken to assess for any correla- Noli': Sub jec ts with and wi tho u t I'rader-Willi syndro me (I'WS) were mat ched fo r age and sex an d then co m pared with respeCl to the var iabl es listed in th e tabl e. HMI = bod y mass index calcu lated as weighr in kilograms di vided by height in meters squared: e ReL =
C h ild Behavior Checklis t (sec text).
rion between BMI, YBO C S scores, or total CBCL score. None of these were significant.
YSOCS
Both the number and severity of OC sympto ms were compared across groups using a Mann-Whitney U test. A non parametric statistical analysis was chosen because of the small numbers in each group and the uncertain distribution of the data. The Prader-Willi group showed significantly more OC sympto ms than the PWS-like cont rols. Figure 1A shows the distribution of scores for YBO CS sympto m number and the mean s and standa rd deviations for each group. Relative to controls, subjects with PWS also had sig n ifica n tly higher ratings o f sympto m severity (Fig. 1B) .
CSCL
To clarify these findings, we conducted follow-up one-way ANOVAs with 4 selected items from the CBCL: ob sessions, overeating, compulsions, and skin picking. In all 16 subjects, endor sements on the CBCL item regard ing obsessions were related to food. Consistent with our hypotheses. the 2 groups had similarly high levels of food obsession s and overeating. However, the PWS group demonstrated significam ly more compulsio ns and skin picking th an co nrrols. Table 2 sum marizes the mean s, sta nda rd deviations, and F values for th e PWS and PWS-like groups.
DISCUSSION
Patients with PWS had significantly higher numbers o f non-food-related OC sym pto ms as well as significantly increased levels of sympto m-related severity com- pa red with co ntrols. O ur find ings are parti cularl y rob ust in th at we co m pared subject s wi th PWS with a group of age-an d gender-mat ch ed d evelo p me nta lly del ayed , o bese . food-preoccupied sub jects , Importantl y. PW S and PWS-like groups were simi lar with respect to IQ . levels of food-relat ed di fficult ies, and overall levels of psychopath ology based o n C BC:L sco res, W h ile th e PWS-l ike gro u p tended towa rd h igh er mean we igh ts th an th e PW S gro u p, ne ith er weigh t no r BMI was related [ ). The present study expands o n th e cu rrent literature by allow ing us to control fo r so me of the key ph en ot ypi c features of PW S while assessing the relation ship hetween OC sym ptoms and geno type . In ligh t of th ese data. the he ightened levels of OC sym ptoms in PW S ca nno t be acco u nt ed for sim ply as a result of patients havin g food preoccupations, o besity, and/or developmental delay. T he 2 groups were equa lly food-obsessed, had sim ilar cog nitive abilities. and had similar degrees of obe sity. It is possible that eating di fficu lt ies are experi en ced di fferently by PWS pati ents than by o ther developmentally delayed . obese adolescents and children and th erefo re resu lt in part icularly severe psychological o u tco mes. However, all the availabl e ind ices measured suggest th at th e 2 gro u ps of pat ients in th is study not o nly were equally sub ject to food -related problem s bur also were equ ally pron e to psychop ath ology in genera l, th ou gh not th e development of O C sym pto ms in part icular.
Report ing biases are unlikely to have influ en ced these findings. If parents an d caregivers of PW S pat ients were mis tak ing food p reoccu pations with o t her non -fo odrelated OC sym ptoms, o ne wou ld presume th at the par-3. n ents and caregivers of the PWS-Iike subjects would demonstrate a similar propensity. Also, given the composition of the control group, the bias toward reporting symptoms consistent with PWS would likely influence both sets of subjects. This is particularly the case as the PWS-like group generally sought evaluation because a clinical diagnosis of PWS had been suggested. In practice, it was usual for parents and caregivers of subjects in this group to be familiar with the clinical picture of PWS and to present with a stated hope of obtaining a diagnosis.
The emerging identification of a behavioral phenotype in PWS raises the intriguing question of how the underlying genetic lesion(s) might lead to these complex neuropsychiatric symptoms. In the case of PWS, no distinct brain area has been identified as grossly pathological by neuroimaging techniques, though there is but a single controlled study in the current literature (Miller et al., 1996) . The syndrome is thought, however, to involve significant hypothalamic dysfunction. This hypothesis is supported by the common occurrence of growth hormone abnormalities, temperature and sleep abnormalities, and delayed sexual maturation in PWS (Bray, 1992; Seyler et al., 1979; Swaab, 1997) . In addition, a recent neuropathological study in PWS found a decrease in oxytocin (OXT) secreting neurons in the hypothalamic paravcntricular nucleus of postmortem PWS brains compared with matched control brains (Swaab ct al., 1995) . OXT abnormalities have been linked to OC symptoms more broadly through research which has demonstrated abnormally high levels of this neuropeptide in the CSF of a subgroup of patients with OCD (Leckman et al., 1994; Swedo et al., 1992) . In addition, we have identified OXT elevations in the CSF of 5 patients with PWS (Martin et al., 1998) compared with controls. It is difficult to reconcile the apparently conflicting findings that OC symptoms and PWS appear in some cases to be associated with increased CSF OXT while there also seems to be a significant decrease in OXT neurons in at least one important CNS nucleus in PraderWilli subjects. It is possible, however, that the techniques used to identify OXT neurons in Swaabs study were not able to distinguish between a paucity of OXT-secreting cells and a normal population of cells that had been relatively depleted of OXT Regardless, what is clear at present is that multiple lines of investigation point to the hypothalamus as the prime brain region for additional research into the relationship between the genetic underpinnings of PWS and its many behavioral consequences.
I. AM. ACAD. CIIIII) AIH)I.FS( I'SYCIIIATRY.\H:\. ,\IAR('1I 1')')<) oc:n SYMPTOMS AND PRADER-WIl.l.I SYNDROME Several methodological shortcomings limit the strength of our findings. This study relied on a relatively small number of patients, limited by the rarity of our natural control group. Larger numbers would have allowed for an analysis of OC symptom profiles both within and between groups as well as for some assessment of genotype-phenotype relationships in PWS patients. Furthermore, the study was naturalistic in that it included patients who presented for clinical evaluation. A~a result, patients with other psychiatric and medical diagnoses and those taking medications were not excluded. Of note, only a single patient was being treated with an antiobsessional medication at the time these symptoms were assessed. This subject was in the PWS-like group. However, excluding this patient in a repeated analysis of the data had no impact on the statistical significance of any of the results.
While the 2 groups appear to very similar along a number of important criteria, there may have been some undetected differences between them, apart from the differences in genetic status, which would account for the significant findings with respect to OC symptoms. Moreover, while the molecular genetic techniques used to distinguish the 2 groups are able to identify more than 95% of patients with the PWS genotype, it is possible that some patients in our PWS-like group could have had an undetected PWS genotype. However, given the direction of the differences found between the 2 groups, inclusion of PWS patients in our PWS-Iike group would have served to minimize the differences between groups, making our findings even less likely to represent a type I error. It should be noted that our PWS group consisted only of patients whose syndrome was caused by a deletion of chromosome 15. While at present there do not appear to be important phenotypic differences between patients with varying types of lesions associated with PWS (Cassidy et al., 1997; Mitchell et al., 1996) , further investigations are needed to clarify this issue as it pertains to behavioral and psychiatric sequelae. Under the circumstances, we considered it prudent to rely on a homogeneous group with respect to genetic causation.
Despite these limitations, our data extend findings from several groups regarding the presence of OC symptoms in PWS patients and the central role of such symptoms in the PWS behavioral phenotype. The ongoing clarification of this phenotype may provide relevant information to psychiatrists and other physicians who treat persons with PWS. Moreover, the continuing inves-tigation into the relationsh ips between genetic abnormalities and behavioral phenotypes promises to shed new light on the co m plex int erpla y of genes, brain, and behavior in the etiology of psychiatric illnesses.
Clinical Implications
The elu cidation of particular psych iatri c sym p to m clusters in persons with PWS will help clinicians anticipate and recognize key behavioral difficulties th at afflict these pat ients and will highli ght for clinicians the importance of assessing and treat ing all the varied aspects of this sy nd ro m e. A better understanding of th e PWS behavioral pheno type should also provide families and patients with a sounder basis for their expectatio ns about the course and natural history of the disorder. Finally, the clarific ati on of th e relationship between OC sym pto ms and PWS ma y serve as an impetus for mu ch-needed clinical in vestigati ons of an tio bsessio nal tr eatments, pharmacological and otherwise. aim ed at helping those with PWS.
